“forbion-capital-partners” Archives

Entry Author Date Location
UniQure to Yank Pioneering Gene Therapy From Market in Europe 04/20/17 Boston
West Coast Bio Roundup: CRISPR Patent, HCV Data, Verily Digs & More 02/19/16 San Francisco
Akarna Therapeutics Secures $15,000,000 Series B Round 02/17/16 San Diego
East Coast Bio Roundup: NY Startups, Editas, Bonney, C4 & (Much) More 01/08/16 Boston
Exosome Diagnostics Closes $60M Series B for Liquid Biopsy Test 01/07/16 Boston
Exosome Diagnostics Garners $60,000,000 Series B Financing Round 01/07/16 Boston
Exosome Diagnostics Lands $17,600,000 Series B Round 09/04/15 Boston
Exosome Dx, Aiming to Commercialize “Liquid Biopsies,” Seeks $25M 01/28/15 Boston
East Coast Biotech Roundup: ImmusanT, NY Disruptors, Tesaro, & More 03/14/14 Boston
Exosome Diagnostics Obtains $27,000,000 Series B Funding Round 03/11/14 New York
Bluebird Prices Ahead of Range, Takes Flight on Nasdaq Today 06/19/13 Boston
Bluebird Bio Snags $60M From Existing VCs and Newcomers Like Shire 07/25/12 Boston
Mitralign Lands $35,000,000 Series D Round 05/16/12 Boston
Promedior Moves Fibrosis Pipeline to Boston, Hires Shire Vet as CEO 05/15/12 Boston
CircuLite Attracts Big Support for Tiny Heart-Assist Device 01/05/12 New York
Exclusive: Pathway Medical Technologies To Be Acquired by Bayer’s Medrad Unit for $125M 08/19/11 Seattle
eBay Acquires Where, Bluebird Calls In $30M, Humedica Gets $20M, & More Boston-Area Deals News 04/27/11 Boston
Bluebird Bio Snaps up $30M for Gene Therapies, Adds ARCH Venture to Syndicate 04/20/11 Boston
bluebird bio Receives $30,000,000 Series C Financing Round 04/20/11 Boston
Bluebird Bio Inks AFM Development Deal 03/16/11 Boston
PneumRx Raises $33M 01/04/11 San Francisco
Exosome Diagnostics Receives $20,000,000 Series A Round 05/12/10 New York
Genetix Gets $35M for Gene Therapy, FDA Delays Decision on Alkermes/Amylin Drug, MedMinder and Vitality Tackle Medication Compliance, & More Boston-Area Life Sciences News 03/19/10 Boston
Genetix Pharma Raises $35M from Third Rock, Genzyme for Gene Therapy 03/12/10 Boston
GENETIX Pharmaceuticals Garners $35,000,000 Series B Round 03/12/10 Boston
Washington Venture Investing Gravitates to Biotech—The Regional Top 10 List 07/21/09 Seattle
Lilliputian Discovers $25M, Biovex Bags $40M, Clinical Data Cedes Cogenics to Beckman Coulter for $17M, & More Boston-Area Deals News 04/06/09 Boston
Genzyme Shrinks Gene Therapy Effort, Expands Oncology; BioVex Raises $40M For Cancer-Fighting Viruses; Biogen Looks to Future of MS Franchise; & More Boston-Area Life Sciences News 04/01/09 Boston
Pathway Raises $40M, Bsquare Brings Flash to Android, Vioguard Hits Up Angels, & More Seattle-Area Deals News 03/31/09 Seattle
BioVex Raises $40M for Cancer-Fighting Virus 03/30/09 Boston
Page 1 of 1